In this episode, we’re delighted to welcome Alan Rigby to Gravity Encounters. With a career spanning academia, biotech, and drug discovery, Alan has made a significant impact on cancer research and immunotherapy. From his time as an Assistant Professor at Harvard to leading multiple innovative companies, he has been at the forefront of tumor biology, computational drug discovery, and antibody therapeutics. Now the CEO of Epitopea, Alan continues to drive breakthroughs in the field, shaping the future of cancer immunotherapies and vaccines.